Burning Rock Biotech (BNR) Total Current Liabilities (2021 - 2023)

Burning Rock Biotech has reported Total Current Liabilities over the past 3 years, most recently at $36.6 million for Q4 2023.

  • Quarterly results put Total Current Liabilities at $36.6 million for Q4 2023, down 36.77% from a year ago — trailing twelve months through Dec 2023 was $36.6 million (down 36.77% YoY), and the annual figure for FY2023 was $37.1 million, down 39.47%.
  • Total Current Liabilities for Q4 2023 was $36.6 million at Burning Rock Biotech, down from $57.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for BNR hit a ceiling of $58.2 million in Q4 2021 and a floor of $36.6 million in Q4 2023.
  • Median Total Current Liabilities over the past 3 years was $57.9 million (2022), compared with a mean of $50.9 million.
  • Biggest five-year swings in Total Current Liabilities: decreased 0.62% in 2022 and later tumbled 36.77% in 2023.
  • Burning Rock Biotech's Total Current Liabilities stood at $58.2 million in 2021, then fell by 0.62% to $57.9 million in 2022, then tumbled by 36.77% to $36.6 million in 2023.
  • The last three reported values for Total Current Liabilities were $36.6 million (Q4 2023), $57.9 million (Q4 2022), and $58.2 million (Q4 2021) per Business Quant data.